Westbourne Investments’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-17,415
Closed -$1.51M 161
2026
Q1
$1.51M Sell
17,415
-185
-1% -$17.7K 0.72% 48
2025
Q4
$1.69M Sell
17,600
-2,225
-11% -$216K 0.79% 40
2025
Q3
$1.8M Sell
19,825
-1,490
-7% -$137K 0.86% 41
2025
Q2
$1.86M Hold
21,315
0.99% 32
2025
Q1
$1.92M Buy
+21,315
New +$1.91M 1.16% 27

Other funds holding MDT

Westbourne Investments's MDT Position: Q2 2026 in Review

Westbourne Investments sold out of Medtronic (MDT) in Q2 2026, closing a stake of 17,415 shares — an estimated $1.51M sold.

Westbourne Investments first reported a position in MDT in Q1 2025 and held it in 5 quarters. The position peaked at $1.92M in Q1 2025. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Westbourne Investments reported no remaining Medtronic position as of Q2 2026 after selling out during the quarter.
  • Westbourne Investments sold 17,415 Medtronic shares in Q2 2026, an estimated $1.51M.
  • Westbourne Investments first reported a position in Medtronic in Q1 2025 and held it in 5 quarters.
  • Westbourne Investments's Medtronic position peaked at $1.92M in Q1 2025.
  • 2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Westbourne Investments's 13F filing for Q2 2026, filed 11 Aug 2026.